Hydrocortisone Valerate Ointment USP, 0.2%

 

  • Hydrocortisone Valerate Ointment USP, 0.2%, is pharmaceutically equivalent (similar) to the brand Westcort®(hydrocortisone valerate) ointment, a medium potency topical (external use) steroid used to treat different types of dermatitis in adults.
  • Hydrocortisone Valerate Ointment USP, 0.2%, is formulated in a hydrophilic ointment base with ingredients to help keep skin hydrated and moisturized.

Hydrocortisone Valerate Ointment USP, 0.2%, is approved by the FDA for use on the skin as an anti-inflammatory and anti-itch agent to relieve the symptoms of different types of dermatitis

Next Steps

Print out our ASK YOUR DOCTOR form and bring it with you to your dermatology appointment.  During your visit, don’t forget to ask your doctor about the PruGen $0 Co-pay program, the best-value in dermatology.

Important Information

Indication

Hydrocortisone Valerate Ointment, 0.2% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.

 

Important Safety Information

  • Hydrocortisone valerate ointment USP, 0.2% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
  • Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment.
  • Patients applying a topical steroid to a large surface area or to areas under occlusion should be evaluated periodically for evidence of HPA axis suppression.
  • Care should be taken when prescribing this product for use on the face, underarms, or groin areas.
  • As with other corticosteroids, therapy should be discontinued when control is achieved.
  • Safety of this product in pediatric patients has not been established.
  • In controlled clinical trials, the total incidences of adverse reactions were worsening of condition, transient itching, irritation and redness.

 

For additional safety and other information, including Patient Information, please see Full Prescribing Information. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.